|4Jun 20, 8:15 AM ET

Hoberman Kenneth 4

4 · Nuvectis Pharma, Inc. · Filed Jun 20, 2023

Insider Transaction Report

Form 4
Period: 2023-06-16
Transactions
  • Award

    Common Stock

    2023-06-16+18,00073,140 total
Footnotes (1)
  • [F1]The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates.

Documents

1 file
  • 4
    tm2319007-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT